What actually happens when a multinational has validated technology that isn't moving? The science works. The patents are clean. The market is real. And yet the technology stays parked. In this episode of INNVENTURING, host Chad Arnold sits down with Colin Scott, Head of New Company Development at Innventure, to pull back the curtain on exactly how Innventure finds, evaluates, and builds transformative companies.

Bill Haskell and Roland Austrup break down Innventure's inflection point — commercial traction across Accelsius, AeroFlexx, and Refinity, plus a new self-funding model built to reward shareholders.

Technologies don't fail because they don't work. They fail because teams pursue inventor interest instead of validated market needs, corporate structures can't accommodate ventures outside strategic mandates, and capital structures don't match actual commercialization timelines. The $940 billion opportunity represents unrealized potential, not readily accessible value — and closing the gap requires capabilities most entities haven't developed.